All Stories

  1. The MAP kinase-interacting kinases (MNKs) as targets in oncology

    Article • Expert Opinion on Therapeutic Targets, January 2019, Taylor & Francis

    Dr Jianling Xie

  2. mTOR inhibitors in cancer therapy

    Article • F1000Research, August 2016, Faculty of 1000, Ltd.

    Dr Jianling Xie